Inventor · disambiguated record
Nobutaka Fujii
Also filed as: FUJII NOBUTAKA
20 granted patents·2 pending applications·531 citations·filing 1986–2011
96Inventor score
Files withBIOKINE THERAPEUTICS LTD4FUJII NOBUTAKA4SEIKAGAKU KOGYO CO LTD2SHINETSU CHEMICAL CO2ARIGEN PHARMACEUTICALS INC1
Top patents by PatentIndex Score
22 records- 0196US5449752APolypeptides with affinity to lipopolysaccharides and their usesSEIKAGAKU KOGYO CO LTD·Filed 1992·Granted Sep 12, 1995·243 cites·9 claims
- 0294US7595298B2Polypeptides having anti-HIV activity and compositions comprising sameBIOKINE THERAPEUTICS LTD·Filed 2006·Granted Sep 29, 2009·26 cites·18 claims
- 0393US8017585B2CXCR4 antagonist and use thereofBIOKINE THERAPEUTICS LTD·Filed 2008·Granted Sep 13, 2011·34 cites·15 claims
- 0491US8410059B2CXCR4 antagonist and use thereofFUJII NOBUTAKA·Filed 2011·Granted Apr 2, 2013·19 cites·3 claims
- 0590US7423007B2Cxcr4 antagonist and use thereofBIOKINE THERAPEUTICS LTD·Filed 2003·Granted Sep 9, 2008·41 cites·23 claims
- 0690US7138488B2Polypeptides having anti-HIV activity and compositions comprising sameBIOKINE THERAPEUTICS LTD·Filed 2001·Granted Nov 21, 2006·35 cites·11 claims
- 0785US8435939B2Polypeptide anti-HIV agent containing the sameFUJII NOBUTAKA·Filed 2009·Granted May 7, 2013·3 cites·21 claims
- 0884US9034814B2CXCR4 antagonists for wound healing and re-epithelializationPELED AMNON·Filed 2006·Granted May 19, 2015·3 cites·18 claims
- 0983US8592379B2Metastin derivative and use thereofFUJII NOBUTAKA·Filed 2009·Granted Nov 26, 2013·9 cites·5 claims
- 1078US6800611B2Metastin derivatives and their useTAKEDA CHEMICAL INDUSTRIES LTD·Filed 2003·Granted Oct 5, 2004·20 cites·10 claims
- 1175US8183212B2Compound having GPR54 agonistic activityFUJII NOBUTAKA·Filed 2006·Granted May 22, 2012·3 cites·9 claims
- 1274US7495011B2Anti-coronavirus drugARIGEN PHARMACEUTICALS INC·Filed 2004·Granted Feb 24, 2009·4 cites·3 claims
- 1373US5571892APolypeptide and anti-HIV drug prepared therefromSEIKAGAKU KOGYO CO LTD·Filed 1991·Granted Nov 5, 1996·31 cites·15 claims
- 1467US6855323B2Identification of the domain of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) that mediates adhesion to chondroitin sulfate AUS HEALTH·Filed 2002·Granted Feb 15, 2005·4 cites·8 claims
- 1556US5059679AMethod of selectively sulfating peptidesSHINETSU CHEMICAL CO·Filed 1989·Granted Oct 22, 1991·15 cites·4 claims
- 1655US4743677ACalcitonin gene related peptide derivativesTOYO JOZO KK·Filed 1986·Granted May 10, 1988·15 cites·3 claims
- 1749US6545125B1Compounds with antitumor activityCHUGAI PHARMACEUTICAL CO LTD·Filed 1998·Granted Apr 8, 2003·11 cites·20 claims
- 1845US5710128APharmaceutical compositions of lipopolysaccharide-binding polypeptidesFiled 1995·Granted Jan 20, 1998·9 cites·9 claims
- 1943US2009036416A1Novel CXCR4 Antagonist and Use ThereofUNIV KYOTO·Filed 2006·Application pending·0 cites
- 2041US2011014649A1Method for production of n36-binding peptideGEKKEIKAN KK·Filed 2007·Application pending·0 cites
- 2138US4950418AReagent for removing protective groups in peptide synthesisSHINETSU CHEMICAL CO·Filed 1989·Granted Aug 21, 1990·6 cites·6 claims
- 2225US8772297B2TGF-β signal transduction inhibitorKAKEYA HIDEAKI·Filed 2011·Granted Jul 8, 2014·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Nobutaka Fujii files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →